1. Home
  2. LSTA vs GTIM Comparison

LSTA vs GTIM Comparison

Compare LSTA & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • GTIM
  • Stock Information
  • Founded
  • LSTA 1980
  • GTIM 1987
  • Country
  • LSTA United States
  • GTIM United States
  • Employees
  • LSTA N/A
  • GTIM N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • GTIM Restaurants
  • Sector
  • LSTA Health Care
  • GTIM Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • GTIM Nasdaq
  • Market Cap
  • LSTA 20.0M
  • GTIM 19.6M
  • IPO Year
  • LSTA N/A
  • GTIM 1990
  • Fundamental
  • Price
  • LSTA $2.18
  • GTIM $1.69
  • Analyst Decision
  • LSTA Strong Buy
  • GTIM
  • Analyst Count
  • LSTA 1
  • GTIM 0
  • Target Price
  • LSTA $15.00
  • GTIM N/A
  • AVG Volume (30 Days)
  • LSTA 10.9K
  • GTIM 21.6K
  • Earning Date
  • LSTA 05-08-2025
  • GTIM 05-08-2025
  • Dividend Yield
  • LSTA N/A
  • GTIM N/A
  • EPS Growth
  • LSTA N/A
  • GTIM 66.31
  • EPS
  • LSTA N/A
  • GTIM 0.10
  • Revenue
  • LSTA $1,000,000.00
  • GTIM $144,332,000.00
  • Revenue This Year
  • LSTA N/A
  • GTIM N/A
  • Revenue Next Year
  • LSTA N/A
  • GTIM N/A
  • P/E Ratio
  • LSTA N/A
  • GTIM $19.14
  • Revenue Growth
  • LSTA N/A
  • GTIM 4.15
  • 52 Week Low
  • LSTA $1.87
  • GTIM $1.80
  • 52 Week High
  • LSTA $4.20
  • GTIM $3.45
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 44.79
  • GTIM 34.89
  • Support Level
  • LSTA $2.07
  • GTIM $1.82
  • Resistance Level
  • LSTA $2.46
  • GTIM $1.90
  • Average True Range (ATR)
  • LSTA 0.17
  • GTIM 0.12
  • MACD
  • LSTA -0.02
  • GTIM -0.00
  • Stochastic Oscillator
  • LSTA 22.92
  • GTIM 0.00

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.

Share on Social Networks: